Lixte Biotechnology Holdings Inc

General ticker "LIXT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $4.5M

Lixte Biotechnology Holdings Inc does not follow the US Stock Market performance with the rate: -22.7%.

Estimated limits based on current volatility of 6.0%: low 1.91$, high 2.13$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.25$, 4.49$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.49$, 4.86$]

Financial Metrics affecting the LIXT estimates:

  • Negative: Non-GAAP EPS, $ of -2.70 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -49.52 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term LIXT quotes

Long-term LIXT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $6.72MM $6.31MM $5.09MM
Operating Income $-6.72MM $-6.31MM $-5.09MM
Non-Operating Income $-0.01MM $-0.00MM $0.00MM
Interest Expense $0.01MM $0.01MM $0.00MM
R&D Expense $1.74MM $1.35MM $0.90MM
Income(Loss) $-6.73MM $-6.31MM $-5.09MM
Profit(Loss) $-6.73MM $-6.31MM $-5.09MM
Stockholders Equity $4.79MM $5.17MM $3.99MM
Assets $5.09MM $5.56MM $4.31MM
Operating Cash Flow $-4.14MM $-4.61MM $-4.29MM
Financing Cash Flow $3.90MM $5.14MM $3.14MM
Earnings Per Share* $-5.00 $-39.85 $-2.66

* EPS are Split Adjusted, recent splits may be reflected with a delay.